Email Updates

You are here

Webinar & Meeting Reports

  • April 25, 2023

    Tuesday, April 25 at 9:00 AM–10:30AM ET
    Despite a dynamic research and development (R&D) pipeline for prevention products, male and female condoms remain the only multi-purpose prevention technologies (MPTs) currently available. Yet MPTs are an integral part of the HIV prevention advocacy agenda. For decades, advocates have pushed for products to be developed that simultaneously prevent HIV, other sexually transmitted infections (STIs) and/or pregnancy.

  • March 29, 2023

    Wednesday, March 29 at 9:30–11:00am ET

    MPX NYC: A community-led study on queer sex in New York City
    Dr. Keletso Makofane, Harvard University, FXB Health & Human Rights Fellow

  • March 28, 2023

    Tuesday, March 28 at 9:00 am ET

    As the number of cure-related clinical trials grows, so does the number of people experiencing month-long delays in viral rebound. A very small handful of participants remain off therapy long after the trial ends. These individuals who can control HIV without therapy after an intervention are known as controllers.

  • March 23, 2023

    Thursday, March 23 at 10:00–11:30am ET

    Speakers will include community leaders and researchers reflecting on the most interesting, consequential science presented at CROI 2023.

  • February 19, 2023 to February 23, 2023

    The annual Conference on Retroviruses and Opportunistic Infections (CROI) took place from February 19 through February 22 in Seattle, Washington. This was the first in-person CROI since 2019, but also included the virtual component honed during COVID, with 3,000+ individuals registered to participate in-person and 500+ online.

    Below are highlights from the conference:

  • January 25, 2023

    A Phase 3 study of an investigational HIV vaccine regimen has been discontinued following a planned, interim review by the study’s independent Data and Safety Monitoring Board. The investigational vaccine was generally safe and well tolerated; however, it was not effective at preventing the acquisition of HIV-1.

  • December 8, 2022

    Thursday, December 8 at 15:00 PM EAT / 14:00 PM SAST/ 13:00 PM WAT / 8:00 AM EDT marks the launch of the inaugural Domestic Resource Mobilization (DRM) Learning Collaborative. The collaborative will be a facilitated virtual space that brings together global health advocates, civil society organizations and other key stakeholders from Africa to engage in peer-to-peer learning and collaboration.

  • December 7, 2022

    The 2022 Global Health Landscape Symposium (GHLS2022) convened from December 7-8 asking the question "How do we meet this moment?" three years after an ongoing pandemic and three years since the Global Health Community last met in person. The agenda, videos and a partner toolkit are available here.

  • November 28, 2022

    Join AVAC for a conversation with NIAID Director, Anthony Fauci as we discuss all that’s been accomplished in the HIV and COVID-19 responses over the years, what’s ahead, and what the future looks like for NIAID, for Dr. Fauci and for pandemic preparedness.

  • November 17, 2022

    Many of the drivers of gender inequality in the HIV epidemic are the same as those driving inequality in the COVID-19 pandemic. During the COVID-19 pandemic, women and girls are at heightened risk of domestic violence and inadequate access of essential health care including HIV prevention and sexual and reproductive health services.